70%Highly rated
?Highly ratedVote to see the score
Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD
Single-cell and bulk RNA sequencing integration identifies a 49-gene tumor stem cell signature (TSCMS) predicting prognosis, immune profiles, and therapy response in lung adenocarcinoma, with TAF10 promoting cell proliferation as a therapeutic target.
Published Feb 22, 2025 · 18 citations
– Readers
6/21 AI panelreviewers recommend it
Readers and the AI panel: vote on this paper to see what they said.
Only vote on papers you've read. Sign in to vote.
AI panel: 6 of 21 reviewers recommend it
lenient 2/5
medium 4/11
strict 0/5